| abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to the field of biotechnology, specifically to the production of subunit vaccines against Mycoplasma spp., and can be used in medicine to prevent the infection of Mycoplasma spp. Vaccine compositions based on protein XylF with SEQ ID NO:9 in combination with a pharmaceutically acceptable adjuvant or a pharmaceutically acceptable additive.EFFECT: invention ensures the achievement of strong immune effects against Mycoplasma spp.5 cl, 9 tbl, 3 ex, 4 dwg |